Hillstream BioPharma "announced the pricing of an underwritten public offering of 5,300,000 shares of its common stock. Each share is being sold to the public at a price of $0.50 for gross proceeds of $2,650,000, before deducting underwriting discounts and offering expenses. ThinkEquity is acting as sole book-running manager for the offering."
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HILS:
- Hillstream BioPharma Announces Pricing of Public Offering
- Hillstream BioPharma Announces Proposed Public Offering
- Hillstream BioPharma announces common stock offering, no amount given
- Hillstream BioPharma selects OncoBay to advance development of HSB-1216
- Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism